Nobel Prize winner French Virologist Prof. Luc Montagnier

“There are antibodies, created by the vaccine,” forcing the virus to “find another solution” or die. This is where the variants are created. It is the variants that “are a production and result from the vaccination.” ~Prof. Luc Montagnier 

(In other words, viruses outsmart antibodies just as they outsmart antibodies produced by vaccines.)

***

Antibody Dependent Enhancement:

Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies Frontiers in Immunology

“Given past data on multiple SARS-CoV-1 and MERS-CoV vaccine efforts have failed due to ADE in animal models (7581), it is reasonable to hypothesize a similar ADE risk for SARS-CoV-2 antibodies and vaccines. ADE risks may be associated with antibody level (which can wane over time after vaccination) and also if the antibodies are derived from prior exposures to other coronaviruses. In addition, ADE with mast cells likely plays a role in MIS-C for infants and possibly older MIS-C and MIS-A patients. While expanded trophism of SARS-CoV-2 represents a possible ADE risk in the subset of COVID-19 patients with disease progression beyond the mild disease stage.”

***

Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination ? Journal of Infection, August 9, 2021

“Since our data indicate that Delta variants are especially well recognized by infection enhancing antibodies targeting the NTD, the possibility of ADE should be further investigated as it may represent a potential risk for mass vaccination during the current Delta variant pandemic. In this respect, second generation vaccines7 with spike protein formulations lacking structurally-conserved ADE-related epitopes should be considered.”

***

“The specific and significant COVID-19 risk of ADE should have been and should be prominently and independently disclosed to research subjects currently in vaccine trials, as well as those being recruited for the trials and future patients after vaccine approval, in order to meet the medical ethics standard of patient comprehension for informed consent.” pubmed.gov

***


The potential for antibody-dependent enhancement of SARS-CoV-2 infection: Translational implications for vaccine development cambridge.org

***


Nobel Prize Winner Warns Vaccines Facilitate Development of Deadlier COVID Variants, Urges Public to Reject Jabs thenewamerican.com

“As reported by French Soir, in his television interview of April 17, 2020, Montagnier drew attention to the presence of at least half a dozen mini-sequences of the HIV virus grouped together in a short segment of the SARS-Cov2 genome. This observation was published by the mathematician Jean-Claude Perez in February 2020 under the title “Synthetic origin of Covid-19 and Evolution.” These mini-sequences, researchers believe, could be exogenous information elements (EIA), that is, they can have genetic significance. They assert that this unmistakable presence of concentrated EIAs, in relation to HIV but also with the Yoeli Plasmodium parasite, the agent responsible for malaria, would not be natural and therefore would require an adequate strategy to develop a safe and effective vaccine. Montagnier and Perez explain the scientific challenges and complexity to develop vaccines against HIV and malaria, both of which still have no vaccines to combat infection.”

Pfizer says its Covid pill with HIV drug cuts the risk of hospitalization or death by 89% cnbc.com

Novel Oral Antiviral Treatment (Ritonavir) Reduced Risk of COVID-19 Hospitalization, Death by 89% in Phase 2/3 Study pharmacytimes.com

ART (antiretroviral treatment) May Lower Risk of COVID-19 in Persons With HIV ajmc.com

Please feel free to share your thoughts

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s